Strategies for hepatitis B booster vaccination among children: an 8-year prospective cohort study

References

• Ott JJ, Horn J, Krause G, Mikolajczyk RT. Time trends of chronic HBV infection over prior decades-A global analysis. J Hepatol. 2017;66:48–54. doi:10.1016/j.jhep.2016.08.013.
   PubMed Web of Science ®Google Scholar
• WHO. Media centre-hepatitis B-fact sheet; 2017 Jul. http://www.who.int/mediacentre/factsheets/fs204/en/.
   Google Scholar
• Hatzakis A, Van Damme P, Alcorn K, Gore C, Benazzouz M, Berkane S, Buti M, Carballo M, Cortes Martins H, Deuffic-Burban S, et al. The state of hepatitis B and C in the Mediterranean and Balkan countries: report from a summit conference. J Viral Hepat. 2013;20(suppl 2):1–20. doi:10.1111/jvh.2013.20.issue-s2.
   PubMedGoogle Scholar
• Trépo C, Chan HLY, Lok A. Hepatitis B virus infection. Lancet. 2014;384:2053–63. doi:10.1016/S0140-6736(14)60220-8.
   PubMed Web of Science ®Google Scholar
• Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386:1546–55. doi:10.1016/S0140-6736(15)61412-X.
   PubMed Web of Science ®Google Scholar
• Bureau of disease prevention and control of Ministry of health, Chinese Center for disease control and prevention. Sero-epidemiologicalsurvey of hepatitis B among national population. Beijing (China): People’s Medical Press; 2011.
   Google Scholar
• Qiu Y, Ren J, Yao J. Healthy adult vaccination: an urgent need to prevent hepatitis B in China. Hum Vaccin Immunother. 2016;12(3):773–78. doi:10.1080/21645515.2015.1086519.
   PubMed Web of Science ®Google Scholar
• Cui F, Shen L, Li L, Wang H, Wang F, Bi S, Liu J, Zhang G, Wang F, Zheng H, et al. Prevention of chronic hepatitis B after 3 decades of escalating vaccination policy, China. Emerg Infect Dis. 2017;23(5):765–72. doi:10.3201/eid2305.161477.
   PubMed Web of Science ®Google Scholar
• Kim YJ, Li P, Hong JM, Ryu KH, Nam E, Chang MS. A single center analysis of the positivity of hepatitis B antibody after neonatal vaccination program in Korea. J Korean Med Sci. 2017;32:810–16. doi:10.3346/jkms.2017.32.5.810.
   PubMed Web of Science ®Google Scholar
• Alssamei FAA, Al-Sonboli NA, Alkumaim FA, Alsayaad NS, Al-Ahdal MS, Higazi TB, Elagib AA. Assessment of immunization to hepatitis B vaccine among children under five years in rural areas of Taiz, Yemen. Hepat Res Treat. 2017;2017(4):1–6. doi:10.1155/2017/2131627.
   Google Scholar
• Lee P-I, Lee C-Y, Huang L-M, Chang MH. Long-term efficacy of recombinant hepatitis B vaccine and risk of natural infection in infants born to mothers with hepatitis B e antigen. J Pediatr. 1995;126:716–21. doi:10.1016/S0022-3476(95)70398-5.
   PubMed Web of Science ®Google Scholar
• Da Villa G, Roman L, Sepe A, Iorio R, Paribello N, Zappa A, Zanetti AR. Impact of hepatitis B vaccination in a highly endemic area of south Italy and long-term duration of anti-HBs antibody in two cohorts of vaccinated individuals. Vaccine. 2007;25:3133–36. doi:10.1016/j.vaccine.2007.01.044.
   PubMed Web of Science ®Google Scholar
• Wang F, Shen L, Cui F, Zhang S, Zheng H, Zhang Y, Liang X, Wang F, Bi S. The long-term efficacy, 13–23 years, of a plasma-derived hepatitis B vaccine in highly endemic areas in China. Vaccine. 2015;33:2704–09. doi:10.1016/j.vaccine.2015.03.064.
   PubMed Web of Science ®Google Scholar
• Wang YT, Chen TY, Lu -L-L, Wang M, Wang D, Yao H, Fan C, Qi J, Zhang Y, Qu C, et al. Adolescent booster with hepatitis B virus vaccines decreases HBV infection in high-risk adults. Vaccine. 2017;35(7):1064–70. doi:10.1016/j.vaccine.2016.12.062.
   PubMed Web of Science ®Google Scholar
• Su FH, Chu FY, Bai CH, Lin YS, Hsueh YM, Sung FC, Yeh CC. Efficacy of hepatitis B vaccine boosters among neonatally vaccinated university freshmen in Taiwan. J Hepatol. 2013;58:684–89. doi:10.1016/j.jhep.2012.11.036. PMID:23207141.
   PubMed Web of Science ®Google Scholar
• Wang Z-Z, Gao Y-H, Wei L, Jin C-D, Zeng Y, Yan L, Ding F, Li T, Liu X-E, Zhuang H, et al. Long-term persistence in protection and response to a hepatitis B vaccine booster among adolescents immunized in infancy in the western region of China. Hum Vaccin Immunother. 2017;13(4):909–15. doi:10.1080/21645515.2016.1250990.
   PubMed Web of Science ®Google Scholar
• Zanetti A, Desole MG, Romanò L, d’Alessandro A, Conversano M, Ferrera G, Panico MG, Tomasi A, Zoppi G, Zuliani M, et al. Safety and immune response to a challenge dose of hepatitis B vaccine in healthy children primed 10 years earlier with hexavalent vaccines in a 3, 5, 11-month schedule: an open-label, controlled, multicentre trial in Italy. Vaccine. 2017;35:4034–40. doi:10.1016/j.vaccine.2017.05.047.
   PubMed Web of Science ®Google Scholar
• Behre U, Van Der Meeren O, Crasta P, Hanssens L, Mesaros N. Lasting immune memory against hepatitis B in 12–13-year-old adolescents previously vaccinated with 4 doses of hexavalent DTPa-HBV-IPV/Hib vaccine in infancy. Hum Vaccin Immunother. 2015;12(11):2916–20. doi:10.1080/21645515.2016.1202388.
   Web of Science ®Google Scholar
• Avdicova M, Crasta PD, Hardt K, Kovac M. Lasting immune memory against hepatitis B following challenge 10–11 years after primary vaccination with either three doses of hexavalent DTPa-HBV-IPV/Hib or monovalent hepatitis B vaccine at 3, 5 a 11–12 months of age. Vaccine. 2015;33:2727–33. doi:10.1016/j.vaccine.2014.06.070.
   PubMed Web of Science ®Google Scholar
• Van Der Meeren O, Behre U, Crasta P. Immunity to hepatitis B persists in adolescents 15–16 years of age vaccinated in infancy with three doses of hepatitis B vaccine. Vaccine. 2016;34:2745–49. doi:10.1016/j.vaccine.2016.04.013.
   PubMed Web of Science ®Google Scholar
• Norrozi M, Azami A, Sarraf-neduad A, Chitsaz H, Rahmati N. Persistence of anti-HBs antibody and immune memory to hepatitis B vaccine, 18 years after infantile vaccination in students of Tehran University. Res Med. 2016;40(1):36–41.
   Google Scholar
• Spada E, Roman L, Me T, Zuccaro O, Paladini S, Chironna M, Coppola RC, Cuccia M, Mangione R, Marrone F, et al. Hepatitis B immunity in teenagers vaccinated as infants: an Italian 17-year follow-up study. Clin Microbiol Infect. 2014;20:680–86. doi:10.1111/1469-0691.12591.
   Web of Science ®Google Scholar
• Wu Z, Yao J, Bao H, Lu S, Li J, Yang L, Jiang Z, Ren J, Xu K, Ruan B, et al. The effects of booster vaccination of hepatitis B vaccine on children 5–15 years after primary immunization: A 5-year follow-up study. Hum Vaccin Immunother. 2018;14(5):1251–56. doi:10.1080/21645515.2018.1426419.
   PubMed Web of Science ®Google Scholar
• Lu S, Ren J, Li Q, Jiang Z, Chen Y, Xu K, Ruan B, Yang S, Xie T, Yang L, et al. Effects of hepatitis B vaccine boosters on anti-HBs- negative children after primary immunization. Hum Vaccin Immunother. 2017;13(4):903–08. doi:10.1080/21645515.2016. 1260794. PMID:27905821.
   PubMed Web of Science ®Google Scholar
• McMahon BJ, Dentinger CM, Bruden D, Zanis C, Peters H, Hurlburt D, Bulkow L, Fiore AE, Bell BP, Hennessy TW. Antibody levels and protection after hepatitis B vaccine: results of a 22-year follow-up study and response to a booster dose. J Infect Dis. 2009;200(9):1390–96. doi:10.1086/606119. PMID:19785526.
   PubMed Web of Science ®Google Scholar
• Aypak C, Yüce A, Yıkılkan H, Görpelioğlu S. Persistence of protection of hepatitis B vaccine and response to booster immunization in 2- to 12-year-old children. Eur J Pediatr. 2012;171:1761–66. doi:10.1007/s00431-012-1815-4.
   PubMed Web of Science ®Google Scholar
• Yao J, Ren J, Shen L, Chen Y, Liang X, Cui F, Li Q, Jiang Z, Wang F. The effects of booster vaccination of hepatitis B vaccine on anti-HBs negative children 11–15 years after primary vaccination. Hum Vaccin. 2011;7(10):1055–59. doi:10.4161/hv.7.10.15990.
   PubMed Web of Science ®Google Scholar
• Spradling PR, Xing J, Williams R, Masunu-Faleafaga Y, Dulski T, Mahamud A, Drobeniuc J, Teshale EH. Immunity to hepatitis B virus infection two decades after implementation of universal infant hepatitis B vaccination: the association of detectable residual antibody and response to a single hepatitis B vaccine challenge dose. Clin Vaccine Immunol. 2013;20:559–61. doi:10.1128/CVI.00694-12. PMID:23408522.
   PubMedGoogle Scholar
• Chiara F, Bartolucci GB, Cattai M, Piazza A, Nicolli A, Buja A, Trevisan A. Hepatitis B vaccination of adolescents: significance of non-protective antibodies. Vaccine. 2013;32(1):62–68. doi:10.1016/j.vaccine.2013.10.074. PMID:24188755.
   PubMed Web of Science ®Google Scholar